Login / Signup

Massive covidization of research citations and the citation elite.

John P A IoannidisEran BendavidMaia Salholz-HillelKevin W BoyackJeroen Baas
Published in: Proceedings of the National Academy of Sciences of the United States of America (2022)
Massive scientific productivity accompanied the COVID-19 pandemic. We evaluated the citation impact of COVID-19 publications relative to all scientific work published in 2020 to 2021 and assessed the impact on scientist citation profiles. Using Scopus data until August 1, 2021, COVID-19 items accounted for 4% of papers published, 20% of citations received to papers published in 2020 to 2021, and >30% of citations received in 36 of the 174 disciplines of science (up to 79.3% in general and internal medicine). Across science, 98 of the 100 most-cited papers published in 2020 to 2021 were related to COVID-19; 110 scientists received ≥10,000 citations for COVID-19 work, but none received ≥10,000 citations for non-COVID-19 work published in 2020 to 2021. For many scientists, citations to their COVID-19 work already accounted for more than half of their total career citation count. Overall, these data show a strong covidization of research citations across science, with major impact on shaping the citation elite.
Keyphrases
  • coronavirus disease
  • sars cov
  • public health
  • respiratory syndrome coronavirus
  • body composition
  • systematic review
  • electronic health record
  • randomized controlled trial
  • big data
  • climate change
  • medical students